Allergy and Immunology · Miami, FL
NPI
1851389985
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7800 SW 87th Ave, Suite C-340
Miami, FL, 33173
Phone (305) 595-0109
Groups this clinician bills Medicare through
Medicare paid, 2024
$739K
39,004 services
Medicare patients, 2024
298
Average age 74
Drug cost, 2024
$1.6M
1,603 prescriptions
Company payments, 2025
$2,850
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil H Gershman was code J2356 (injection, tezepelumab-ekko, 1 mg), 15,559 times for 14 patients. In total Neil H Gershman billed 39,004 services in 35 codes, and Medicare paid $739K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 15,559 | 14 | $13.81 | $215K |
| J2357 Injection, omalizumab, 5 mg | Office | 6,531 | 18 | $29.86 | $195K |
| 95004 Test - Miscellaneous | Office | 5,259 | 70 | $3.03 | $16K |
| 95165 Treatment - Miscellaneous | Office | 1,120 | 54 | $11.11 | $12K |
| 95024 Test - Miscellaneous | Office | 1,027 | 41 | $6.42 | $6,598 |
| 95117 Treatment - Miscellaneous | Office | 779 | 58 | $8.81 | $6,860 |
| 96372 Injection Administration | Office | 409 | 46 | $11.28 | $4,616 |
| 99213 Office E&M - Established | Office | 315 | 194 | $68.74 | $22K |
| 95115 Treatment - Miscellaneous | Office | 268 | 13 | $7.47 | $2,001 |
| 96160 E&M - Miscellaneous | Office | 156 | 90 | $2.24 | $350 |
| 94375 Pulmonary Function Testing | Office | 84 | 66 | $29.68 | $2,493 |
| 99204 Office E&M - New | Office | 82 | 82 | $124.19 | $10K |
| 94060 Pulmonary Function Testing | Office | 52 | 48 | $30.49 | $1,586 |
| 95012 Pulmonary | Office | 28 | 22 | $14.99 | $420 |
| 99214 Office E&M - Established | Office | 21 | 18 | $99.28 | $2,085 |
By year: 2022 $776K for 34,503 services; 2023 $533K for 27,940 services; 2024 $739K for 39,004 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neil H Gershman prescribed most often to Medicare patients was Montelukast Sodium, with 250 prescriptions and refills. In total Neil H Gershman wrote 1,603 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 250 | 572 | 84 | $2,846 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 183 | 215 | 44 | $131K |
| Fluticasone Propionate Generic | 163 | 323 | 78 | $2,978 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 135 | 144 | 61 | $4,153 |
| Azelastine Hcl Generic | 88 | 185 | 41 | $3,056 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 85 | 20 | $8,004 |
| Levocetirizine Dihydrochloride Generic | 51 | 88 | 18 | $1,011 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 48 | 57 | 17 | $5,277 |
| Breo Ellipta Fluticasone/Vilanterol | 45 | 45 | Under 11 | $16K |
| Prednisone Generic | 45 | 45 | 38 | $87.59 |
| Dupixent Pen Dupilumab | 37 | 37 | Under 11 | $140K |
| Tacrolimus Generic | 35 | 41 | 13 | $5,590 |
| Symbicort Budesonide/Formoterol Fumarate | 34 | 46 | 12 | $9,847 |
| Dupixent Syringe Dupilumab | 33 | 33 | Under 11 | $131K |
| Epinephrine Generic | 30 | 31 | 29 | $6,082 |
Brand drugs: 702 claims; generic drugs: 901 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil H Gershman $2,850 ($2,850 in general payments such as food, travel and fees) from 20 companies. The largest payer was Genzyme Corporation with $720.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 18 | $720 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $544 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 8 | $294 |
| Galderma Laboratories, L.P. GALD.SW | 11 | $271 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $211 |
| GlaxoSmithKline, LLC. GSK | 11 | $181 |
| BioCryst US Sales Co., LLC | 4 | $118 |
| Amgen Inc. AMGN | 3 | $69.93 |
| Pfizer Inc. PFE | 3 | $65.66 |
| Organon LLC OGN | 2 | $54.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.